|
|
|
|
Vol. 60, Issue 3, 432-439, September 2001
Molecular Medicine Laboratories, Institute for Drug Discovery
Research, Yamanouchi Pharmaceutical Co., Ltd., Ibaraki, Japan
Platelet activation plays an essential role in thrombosis. ADP-induced
platelet aggregation is mediated by two distinct G protein-coupled ADP
receptors, Gq-linked P2Y1, and Gi-linked P2TAC, which has not been cloned. The cDNA encoding a novel G protein-coupled receptor, termed HORK3, was isolated. The HORK3
gene and P2Y1 gene were mapped to
chromosome 3q21-q25. HORK3, when transfected in the rat glioma cell
subline (C6-15), responded to 2-methylthio-ADP (2MeSADP)
(EC50 = 0.08 nM) and ADP (EC50 = 42 nM) with inhibition of forskolin-stimulated cAMP accumulation. 2MeSADP
(EC50 = 1.3 nM) and ADP (EC50 = 18 nM) also induced intracellular calcium mobilization in
P2Y1-expressing cells. These results show that HORK3 is a
Gi/o-coupled receptor and that its natural ligand is ADP. AR-C69931 MX
and 2MeSAMP, P2TAC antagonists, selectively inhibited
2MeSADP-induced adenylyl cyclase inhibition in HORK3-expressing cells.
On the other hand, A3P5PS, a P2Y1 antagonist, blocked only 2MeSADP-induced calcium mobilization in P2Y1-expressing
cells. HORK3 mRNA was detected in human platelets and the expression level of HORK3 was equivalent to that of P2Y1. These
observations indicate that HORK3 has the characteristics of the
proposed P2TAC receptor. We have also determined that
[3H]2MeSADP binds to cloned HORK3 and P2Y1.
Competition binding experiments revealed a similarity in the rank
orders of potency of agonists and the selectivity of antagonists as
obtained in the functional assay. These results support the view that
P2Y1 functions as a high-affinity ADP receptor and
P2TAC as a low-affinity ADP receptor in platelets.
This article has been cited by other articles:
![]() |
A. I. Masyuk, S. A. Gradilone, J. M. Banales, B. Q. Huang, T. V. Masyuk, S.-O. Lee, P. L. Splinter, A. J. Stroope, and N. F. LaRusso Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G725 - G734. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yamazaki, M. Aoyama, S. Ohya, K. Muraki, K. Asai, and Y. Imaizumi Novel Functions of Small Conductance Ca2+-activated K+ Channel in Enhanced Cell Proliferation by ATP in Brain Endothelial Cells J. Biol. Chem., December 15, 2006; 281(50): 38430 - 38439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function Mol. Pharmacol., September 1, 2006; 70(3): 1132 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hardy, P. B. Conley, J. Luo, J. L. Benovic, A. W. Poole, and S. J. Mundell P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms Blood, May 1, 2005; 105(9): 3552 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feng, A. G. Mery, E. M. Beller, C. Favot, and J. A. Boyce Adenine Nucleotides Inhibit Cytokine Generation by Human Mast Cells through a Gs-Coupled Receptor J. Immunol., December 15, 2004; 173(12): 7539 - 7547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takasaki, T. Saito, M. Taniguchi, T. Kawasaki, Y. Moritani, K. Hayashi, and M. Kobori A Novel G{alpha}q/11-selective Inhibitor J. Biol. Chem., November 12, 2004; 279(46): 47438 - 47445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ennion, A. D. Powell, and E. P. Seward Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Jarvis, B. Bianchi, J. T. Uchic, J. Cartmell, C.-H. Lee, M. Williams, and C. Faltynek [3H]A-317491, a Novel High-Affinity Non-Nucleotide Antagonist That Specifically Labels Human P2X2/3 and P2X3 Receptors J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Herold, A.-D. Qi, T. K. Harden, and R. A. Nicholas Agonist Versus Antagonist Action of ATP at the P2Y4 Receptor Is Determined by the Second Extracellular Loop J. Biol. Chem., March 19, 2004; 279(12): 11456 - 11464. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Bodor, G. L. Waldo, S. B. Hooks, J. Corbitt, J. L. Boyer, and T. K. Harden Purification and Functional Reconstitution of the Human P2Y12 Receptor Mol. Pharmacol., November 1, 2003; 64(5): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Marteau, E. Le Poul, D. Communi, D. Communi, C. Labouret, P. Savi, J.-M. Boeynaems, and N. S. Gonzalez Pharmacological Characterization of the Human P2Y13 Receptor Mol. Pharmacol., July 1, 2003; 64(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Birk, E. Leno, H. D. Robertson, V. M. Bolotina, and H. H. Szeto Interaction between ATP and catecholamines in stimulation of platelet aggregation Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H619 - H625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Kulick and I. von Kugelgen P2Y-Receptors Mediating an Inhibition of the Evoked Entry of Calcium through N-Type Calcium Channels at Neuronal Processes J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simon, A. K. Filippov, S. Goransson, Y. H. Wong, C. Frelin, A. D. Michel, D. A. Brown, and E. A. Barnard Characterization and Channel Coupling of the P2Y12 Nucleotide Receptor of Brain Capillary Endothelial Cells J. Biol. Chem., August 23, 2002; 277(35): 31390 - 31400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nicholas Identification of the P2Y12 Receptor: A Novel Member of the P2Y Family of Receptors Activated by Extracellular Nucleotides Mol. Pharmacol., September 1, 2001; 60(3): 416 - 420. [Full Text] [PDF] |
||||